Report cover image

Industry Insights: GLP-1 Innovation Landscape 2026

Publisher GlobalData
Published Feb 27, 2026
Length 44 Pages
SKU # GBDT21061154

Description

Industry Insights: GLP-1 Innovation Landscape 2026

Summary

This report is part of a series on key trends which are currently affecting the consumer landscape. This report offers an analysis of the key GLP-1-driven retail and brand food and drinks innovation that are meeting consumer demand in this space.

GLP 1 drugs use (e.g., Ozempic, Wegovy) is rapidly expanding beyond treatments for diabetes and into mainstream weight management because they are effective at increasing satiety and reducing food intake, resulting in rapid weight loss. Usage is surging with global GLP-1 drug sales forecast to rise from $76 billion in 2025 to $162 billion by 2031. GLP‑1 drugs change eating behavior, with users preferring smaller portions and nutrient-dense foods to supplement their reduced dietary intake. Retailers are moving fastest with new innovation in “GLP 1 friendly” food and ready meal ranges, formulated with high protein, high fiber, with balanced nutrient and vitamin content. Brands are reevaluating existing product formulations to boost GLP-1 friendly ingredients.

Scope
  • GLP‑1 adoption is accelerating and becoming a major demand driver: Use is rising quickly, with the global market projected to grow from $76 billion (2025) to $161.9 billion (2031). GLP-1 pills will expand access, but injectables remain the main growth engine.
  • Food needs are shifting because GLP‑1 changes eating behavior: Users eat less, feel full faster, and can be more sensitive to rich foods-creating demand for smaller, nutrient-dense portions that still deliver nutrition.
  • The side effects of GLP-1 drug use (nausea/constipation/diarrhea) open up space for tolerability-supporting products, particularly those with higher-fiber ingredients.
  • Retailers are moving faster in this space than brands with explicit GLP‑1 ranges: UK retailers have launched “GLP‑1 friendly” lines (portion-controlled, high protein/fiber, lower calorie, added micronutrients), setting a template for the market.
  • Brands are mostly taking a cautious approach: many manufacturers are quietly aligning with the needs of GLP-1 users (protein, nutrient density, smaller portions) rather than overtly targeting them.
Reasons to Buy
  • Understand how big the GLP‑1-driven opportunity is, why it matters-and how fast it is scaling with a clear view of adoption and revenue momentum, to help size the commercial opportunity, inspire innovation ideas, and prioritize markets.
  • Discover who is most interested in GLP-I formulated food and drinks, what their formulation requirements are, and how this leads to concrete innovation opportunities.
  • Deep dive into what retailers are doing right now and why it matters-the playbook behind “Jab‑uary” launches, how to present key on-pack messages to convert interest into sales, and what this signals for brands.
  • Understand what winning products need to deliver, where the whitespace is, why “real food” cues matter-and how to use portion control as part of final product delivery.

Table of Contents

44 Pages
Executive Summary
1. Overview
GLP-1 Agonists Explained
GLP-1 GB and US User Numbers
GLP-1 Global Market Forecasts
GLP-1 Wegovy Pill Forecasts
Social Media Analytics
Weight Management Product Sales Forecasts
2. What are the Consumer Drivers?
3. Retail Innovation
4. Brand Innovation
5. GLP-1 Innovation
Takeaways
Appendix

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us